| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | beta-adrenergic receptor kinase activity | 1.89e-05 | 4 | 36 | 2 | GO:0047696 | |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 3.15e-05 | 5 | 36 | 2 | GO:0097109 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor kinase activity | 6.60e-05 | 7 | 36 | 2 | GO:0004703 | |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 2.58e-05 | 34 | 35 | 3 | GO:0097107 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization assembly | 5.65e-05 | 44 | 35 | 3 | GO:0098698 | |
| GeneOntologyBiologicalProcess | excitatory synapse assembly | 6.46e-05 | 46 | 35 | 3 | GO:1904861 | |
| GeneOntologyBiologicalProcess | postsynaptic density organization | 1.30e-04 | 58 | 35 | 3 | GO:0097106 | |
| GeneOntologyBiologicalProcess | iodide transport | 1.52e-04 | 11 | 35 | 2 | GO:0015705 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization organization | 2.36e-04 | 71 | 35 | 3 | GO:0099084 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 3.31e-04 | 16 | 35 | 2 | GO:0007158 | |
| MousePheno | increased chromosomal stability | 4.22e-05 | 6 | 24 | 2 | MP:0010095 | |
| Domain | Syndecan | 6.72e-05 | 7 | 34 | 2 | PF01034 | |
| Domain | GPCR_kinase | 6.72e-05 | 7 | 34 | 2 | IPR000239 | |
| Domain | Syndecan/Neurexin_dom | 6.72e-05 | 7 | 34 | 2 | IPR027789 | |
| Domain | Neurexin-like | 2.89e-04 | 14 | 34 | 2 | IPR003585 | |
| Domain | 4.1m | 2.89e-04 | 14 | 34 | 2 | SM00294 | |
| Domain | - | 6.80e-04 | 95 | 34 | 3 | 2.60.120.200 | |
| Domain | EGF_3 | 8.42e-04 | 235 | 34 | 4 | PS50026 | |
| Domain | EGF | 8.42e-04 | 235 | 34 | 4 | SM00181 | |
| Domain | EGF-like_dom | 1.04e-03 | 249 | 34 | 4 | IPR000742 | |
| Domain | EGF-like_CS | 1.24e-03 | 261 | 34 | 4 | IPR013032 | |
| Domain | EGF_2 | 1.31e-03 | 265 | 34 | 4 | PS01186 | |
| Domain | RGS | 1.84e-03 | 35 | 34 | 2 | PF00615 | |
| Domain | RGS | 1.84e-03 | 35 | 34 | 2 | SM00315 | |
| Domain | RGS | 1.95e-03 | 36 | 34 | 2 | PS50132 | |
| Domain | LAM_G_DOMAIN | 2.17e-03 | 38 | 34 | 2 | PS50025 | |
| Domain | RGS | 2.29e-03 | 39 | 34 | 2 | IPR016137 | |
| Domain | Keratin_B2_2 | 2.29e-03 | 39 | 34 | 2 | PF13885 | |
| Domain | Laminin_G_2 | 2.40e-03 | 40 | 34 | 2 | PF02210 | |
| Domain | Keratin_B2 | 2.40e-03 | 40 | 34 | 2 | PF01500 | |
| Domain | LamG | 2.90e-03 | 44 | 34 | 2 | SM00282 | |
| Domain | 6-blade_b-propeller_TolB-like | 3.17e-03 | 46 | 34 | 2 | IPR011042 | |
| Domain | - | 3.30e-03 | 47 | 34 | 2 | 3.30.420.10 | |
| Domain | CUB | 3.59e-03 | 49 | 34 | 2 | PF00431 | |
| Domain | CUB | 3.73e-03 | 50 | 34 | 2 | SM00042 | |
| Domain | Sushi | 4.03e-03 | 52 | 34 | 2 | PF00084 | |
| Domain | - | 4.03e-03 | 52 | 34 | 2 | 2.60.120.290 | |
| Domain | CUB | 4.18e-03 | 53 | 34 | 2 | PS01180 | |
| Domain | CCP | 4.34e-03 | 54 | 34 | 2 | SM00032 | |
| Domain | SUSHI | 4.66e-03 | 56 | 34 | 2 | PS50923 | |
| Domain | SCAN | 4.66e-03 | 56 | 34 | 2 | SM00431 | |
| Domain | AGC-kinase_C | 4.66e-03 | 56 | 34 | 2 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 4.66e-03 | 56 | 34 | 2 | PS51285 | |
| Domain | S_TK_X | 4.66e-03 | 56 | 34 | 2 | SM00133 | |
| Domain | Sushi_SCR_CCP_dom | 4.82e-03 | 57 | 34 | 2 | IPR000436 | |
| Domain | CUB_dom | 4.82e-03 | 57 | 34 | 2 | IPR000859 | |
| Domain | SCAN_BOX | 4.99e-03 | 58 | 34 | 2 | PS50804 | |
| Domain | SCAN | 4.99e-03 | 58 | 34 | 2 | PF02023 | |
| Domain | Laminin_G | 4.99e-03 | 58 | 34 | 2 | IPR001791 | |
| Domain | KAP | 4.99e-03 | 58 | 34 | 2 | IPR002494 | |
| Domain | SCAN_dom | 4.99e-03 | 58 | 34 | 2 | IPR003309 | |
| Domain | Retrov_capsid_C | 5.16e-03 | 59 | 34 | 2 | IPR008916 | |
| Domain | RNaseH-like_dom | 6.99e-03 | 69 | 34 | 2 | IPR012337 | |
| Domain | ConA-like_dom | 7.28e-03 | 219 | 34 | 3 | IPR013320 | |
| Domain | G-protein_beta_WD-40_rep | 1.04e-02 | 85 | 34 | 2 | IPR020472 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 19658047 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 8638670 | ||
| Pubmed | A genetic association study of CSMD1 and CSMD2 with cognitive function. | 1.04e-06 | 2 | 36 | 2 | 27890662 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 37543682 | ||
| Pubmed | Altered airway and cardiac responses in mice lacking G protein-coupled receptor kinase 3. | 1.04e-06 | 2 | 36 | 2 | 10198406 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 33060647 | ||
| Pubmed | Neurexin I alpha is a major alpha-latrotoxin receptor that cooperates in alpha-latrotoxin action. | 1.04e-06 | 2 | 36 | 2 | 9430716 | |
| Pubmed | The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. | 1.04e-06 | 2 | 36 | 2 | 21439553 | |
| Pubmed | Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients. | 1.04e-06 | 2 | 36 | 2 | 24408017 | |
| Pubmed | G-protein coupled receptor kinase 2 and 3 expression in human detrusor cultured smooth muscle cells. | 1.04e-06 | 2 | 36 | 2 | 11762794 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 8035170 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 10754297 | ||
| Pubmed | Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior. | 3.12e-06 | 3 | 36 | 2 | 34133920 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 38891114 | ||
| Pubmed | Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. | 3.12e-06 | 3 | 36 | 2 | 12036300 | |
| Pubmed | β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling. | 3.12e-06 | 3 | 36 | 2 | 26213384 | |
| Pubmed | Neurexin gene family variants as risk factors for autism spectrum disorder. | 3.12e-06 | 3 | 36 | 2 | 29045040 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 31005376 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 12906867 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 38571813 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 35173587 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 10085131 | ||
| Pubmed | Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. | 3.12e-06 | 3 | 36 | 2 | 7761854 | |
| Pubmed | The N-termini of GRK2 and GRK3 simulate the stimulating effects of RKIP on β-adrenoceptors. | 3.12e-06 | 3 | 36 | 2 | 31604529 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 30858964 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 26279567 | ||
| Pubmed | Neurexins are differentially expressed in the embryonic nervous system of mice. | 3.12e-06 | 3 | 36 | 2 | 7722633 | |
| Pubmed | Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals. | 3.12e-06 | 3 | 36 | 2 | 26446217 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 28013231 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 12130708 | ||
| Pubmed | Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. | 3.12e-06 | 3 | 36 | 2 | 11944992 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 16406382 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 33058888 | ||
| Pubmed | Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules. | 3.12e-06 | 3 | 36 | 2 | 17035546 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 9448462 | ||
| Pubmed | Deletion of α-neurexin II results in autism-related behaviors in mice. | 3.12e-06 | 3 | 36 | 2 | 25423136 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 31812984 | ||
| Pubmed | Postsynaptic N-methyl-D-aspartate receptor function requires alpha-neurexins. | 6.24e-06 | 4 | 36 | 2 | 14983056 | |
| Pubmed | Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. | 6.24e-06 | 4 | 36 | 2 | 8917529 | |
| Pubmed | Zscan5b Deficiency Impairs DNA Damage Response and Causes Chromosomal Aberrations during Mitosis. | 6.24e-06 | 4 | 36 | 2 | 31155506 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 8786425 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 27732952 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 17347997 | ||
| Pubmed | Neurexins cluster Ca2+ channels within the presynaptic active zone. | 6.24e-06 | 4 | 36 | 2 | 32134527 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 32706374 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 21784156 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 8662816 | ||
| Pubmed | Hierarchical organization of multi-site phosphorylation at the CXCR4 C terminus. | 6.24e-06 | 4 | 36 | 2 | 23734232 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 35385735 | ||
| Pubmed | Neurexins regulate presynaptic GABAB-receptors at central synapses. | 6.24e-06 | 4 | 36 | 2 | 33888718 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 28472659 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 36709330 | ||
| Pubmed | Neuroligins and neurexins link synaptic function to cognitive disease. | 1.04e-05 | 5 | 36 | 2 | 18923512 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 10338466 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 20537373 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 36205393 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 9223334 | ||
| Pubmed | Structures, alternative splicing, and neurexin binding of multiple neuroligins. | 1.56e-05 | 6 | 36 | 2 | 8576240 | |
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 9826657 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 30683685 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 36451830 | ||
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 1.56e-05 | 6 | 36 | 2 | 12827191 | |
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 19816407 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 20074556 | ||
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 8672451 | ||
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 29782851 | ||
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 11517230 | ||
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 9856994 | ||
| Pubmed | GluD1 is a signal transduction device disguised as an ionotropic receptor. | 2.91e-05 | 8 | 36 | 2 | 34135511 | |
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 2.91e-05 | 8 | 36 | 2 | 30871858 | |
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 37591863 | ||
| Pubmed | 3.73e-05 | 9 | 36 | 2 | 34873237 | ||
| Pubmed | 3.73e-05 | 9 | 36 | 2 | 9707552 | ||
| Pubmed | 3.73e-05 | 9 | 36 | 2 | 34919427 | ||
| Pubmed | Reduced expression of neuropeptide genes in a genome-wide screen of a secretion-deficient mouse. | 4.66e-05 | 67 | 36 | 3 | 16987237 | |
| Pubmed | Replication study of candidate genes for cognitive abilities: the Lothian Birth Cohort 1936. | 4.66e-05 | 10 | 36 | 2 | 19077115 | |
| Pubmed | 4.66e-05 | 10 | 36 | 2 | 1869533 | ||
| Pubmed | 5.70e-05 | 11 | 36 | 2 | 32973045 | ||
| Pubmed | The contribution of rare and common variants in 30 genes to risk nicotine dependence. | 9.41e-05 | 14 | 36 | 2 | 25450229 | |
| Pubmed | 1.3 A X-ray structure of an antibody Fv fragment used for induced membrane-protein crystallization. | 1.08e-04 | 15 | 36 | 2 | 12657787 | |
| Pubmed | 1.24e-04 | 16 | 36 | 2 | 15028290 | ||
| Pubmed | A genome-wide meta-analysis of association studies of Cloninger's Temperament Scales. | 1.40e-04 | 17 | 36 | 2 | 22832960 | |
| Pubmed | 1.40e-04 | 17 | 36 | 2 | 27779093 | ||
| Pubmed | Cbln1 regulates axon growth and guidance in multiple neural regions. | 2.38e-04 | 22 | 36 | 2 | 36395107 | |
| Pubmed | Early onset of somatic mutation in immunoglobulin VH genes during the primary immune response. | 2.38e-04 | 22 | 36 | 2 | 2499654 | |
| Pubmed | 3.18e-04 | 128 | 36 | 3 | 30995482 | ||
| Pubmed | 3.87e-04 | 28 | 36 | 2 | 38324473 | ||
| Pubmed | A genome-wide association study of behavioral disinhibition. | 4.45e-04 | 30 | 36 | 2 | 23942779 | |
| Pubmed | 5.07e-04 | 32 | 36 | 2 | 38060382 | ||
| Pubmed | 5.26e-04 | 152 | 36 | 3 | 34299191 | ||
| Pubmed | Joint influence of small-effect genetic variants on human longevity. | 5.72e-04 | 34 | 36 | 2 | 20834067 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 7.28e-04 | 1489 | 36 | 7 | 28611215 | |
| Cytoband | 19q13.43 | 2.14e-03 | 87 | 36 | 2 | 19q13.43 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q21 | 2.66e-03 | 97 | 36 | 2 | chr14q21 | |
| Cytoband | 21q22.3 | 4.57e-03 | 128 | 36 | 2 | 21q22.3 | |
| GeneFamily | Exonucleases | 2.36e-04 | 16 | 26 | 2 | 544 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.02e-03 | 57 | 26 | 2 | 1179 | |
| GeneFamily | Keratin associated proteins | 1.07e-02 | 109 | 26 | 2 | 619 | |
| Coexpression | MIKKELSEN_MCV6_LCP_WITH_H3K27ME3 | 7.90e-06 | 30 | 34 | 3 | MM835 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-07 | 170 | 36 | 5 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-07 | 170 | 36 | 5 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-07 | 170 | 36 | 5 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.91e-07 | 195 | 36 | 5 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.04e-07 | 196 | 36 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Schwann|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.43e-07 | 199 | 36 | 5 | 8dc65662c3ca1db2ba0091332f0658abc0afc5de | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Schwann-Schwann_nonmyelinating|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.43e-07 | 199 | 36 | 5 | a92718a3f1153b8d2196fd343ed5bc0ebc98cad7 | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.32e-06 | 155 | 36 | 4 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.10e-06 | 159 | 36 | 4 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 8.10e-06 | 159 | 36 | 4 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.51e-06 | 161 | 36 | 4 | 7d1bc73f4c82465b3f489d6737048b0cd54f22cf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.51e-06 | 161 | 36 | 4 | 410eef62c83c704cbfc5a1b643c4db11bbdcd81f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.51e-06 | 161 | 36 | 4 | 71022485da6754a2b57b4c3e758e3de4c95cc292 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.51e-06 | 161 | 36 | 4 | 59ae8a7c9a04ecaa335b8064852a5a91a21780bd | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.72e-06 | 162 | 36 | 4 | c7114e24cb5525abb9780ca3d35dbcc4eabd4b64 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.72e-06 | 162 | 36 | 4 | f1851a173d3bcca2981d934161ec85d1cc0af5a2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.72e-06 | 162 | 36 | 4 | 5d902bb31e691aea9749617cc88303c2448f24b8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.15e-06 | 164 | 36 | 4 | 43630a448f4369fa9e4e3eccdf3b9f29cec16c39 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.15e-06 | 164 | 36 | 4 | 108fbecb56d69a675d6ce6e826a873ae528f2fd7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.15e-06 | 164 | 36 | 4 | 46208f18325976c89f572f6627aea0582142b92d | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 9.37e-06 | 165 | 36 | 4 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | 1.03e-05 | 169 | 36 | 4 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.03e-05 | 169 | 36 | 4 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-05 | 170 | 36 | 4 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | wk_20-22-Epithelial-PNS|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.13e-05 | 173 | 36 | 4 | 17b1a6b0318925d5d920f2c0a791745b9587ebef | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.24e-05 | 177 | 36 | 4 | 621dd82f1393c961d4dd7a615aa52c9df9e36336 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-05 | 181 | 36 | 4 | 098dbb3e0ff531c9720a233123250c1e39a97d4c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-05 | 183 | 36 | 4 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-05 | 184 | 36 | 4 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 184 | 36 | 4 | 31dbe6119a3bcd266ae5e9b340c853d9ff680dce | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 184 | 36 | 4 | 9c20b50f8d6ac689d41d5440c835f9db8d04758b | |
| ToppCell | PCW_13-14-Neuronal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.44e-05 | 184 | 36 | 4 | 65cf3460125e3dbc34978957bc138a449f71f7df | |
| ToppCell | 18-Distal-Epithelial-Neuroendocrine|Distal / Age, Tissue, Lineage and Cell class | 1.47e-05 | 185 | 36 | 4 | f8fc7b12b4e18d23d84e95488be93c4352d325f3 | |
| ToppCell | SMG-Goblet|World / shred by cell class for bronchial biopsy | 1.53e-05 | 187 | 36 | 4 | 5178118bdec91495253c88f58fd908cf831de7ef | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.67e-05 | 191 | 36 | 4 | 19832ddd559a353e1618fe853d79e3edfec6dcda | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.70e-05 | 192 | 36 | 4 | 4d3a1c267739b1479217144656986972fc86db43 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-05 | 192 | 36 | 4 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-05 | 192 | 36 | 4 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.74e-05 | 193 | 36 | 4 | 8603d1a38955ad2529d04e4704467c73ea5bfbda | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 195 | 36 | 4 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 195 | 36 | 4 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.88e-05 | 197 | 36 | 4 | 5c88a97e8e23a5cd61885acbe1ef339ae6a1e35a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.92e-05 | 198 | 36 | 4 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.92e-05 | 198 | 36 | 4 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 1.92e-05 | 198 | 36 | 4 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.92e-05 | 198 | 36 | 4 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.00e-05 | 200 | 36 | 4 | 838f87cc55652512d240c5952ee4b3870fb2399f | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.00e-05 | 200 | 36 | 4 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.68e-04 | 133 | 36 | 3 | a8abb6b54862123961ae6defbf251ee6e9575258 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.04e-04 | 142 | 36 | 3 | 819e983688d126d89a71abc03d72525cc759a347 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.21e-04 | 146 | 36 | 3 | 03a6a442f1f6d173a41aeebbfe41ee08853d9585 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-04 | 146 | 36 | 3 | 2ac9b487a7991fdc15444aeb93533030e09825bb | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 2.21e-04 | 146 | 36 | 3 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | RV-16._Neuronal|World / Chamber and Cluster_Paper | 2.35e-04 | 149 | 36 | 3 | 3a2f8c4173dcf9e3f8d3b8ffddbc597098adf7a9 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 152 | 36 | 3 | 82a493ffb2f1704cd6f68a82d970fe12f537d20e | |
| ToppCell | RV-16._Neuronal|RV / Chamber and Cluster_Paper | 2.54e-04 | 153 | 36 | 3 | bed8bbf5c5cbfbf46a816066da472c3fdddecb5d | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.58e-04 | 154 | 36 | 3 | 511923b27469ea20f8bd82a9ec27119a6e884644 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.68e-04 | 156 | 36 | 3 | 8353f98e7d393d4299ed1da8f66cfbc7176df1b5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-04 | 160 | 36 | 3 | 14dfa519e68bab4bce890ddb66fa7763f18d9f19 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-04 | 160 | 36 | 3 | 5b7789d4668ed7732babedc32d812233b430e0bd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-04 | 160 | 36 | 3 | bba1486faaad5299e10f4fe17c6d149c28dc2560 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-04 | 160 | 36 | 3 | 839bbdfd4e4c7b48260c8bfb7670378634405e1d | |
| ToppCell | Club_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.94e-04 | 161 | 36 | 3 | bd08a23b415617f6e8748ed2668d578a860ecf91 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.94e-04 | 161 | 36 | 3 | f5da03c426f3124ea302bd343b6bca81cafee858 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.00e-04 | 162 | 36 | 3 | 4e3bf16799c6552366d4c7e42b1328a05dcad7e7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-04 | 162 | 36 | 3 | d28b2ea1d2c8f3c6a107991573471b6d0c49c4ae | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-04 | 162 | 36 | 3 | eed223e61c8162a2fe004ab4e09de5e037be7553 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-04 | 162 | 36 | 3 | 5bbd7130d4dad9035e73a439dda568195c136f31 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-04 | 162 | 36 | 3 | e35ddce830e20ebeac1a2c405293fc4a5323dd4a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-04 | 166 | 36 | 3 | f742d15b02a6f651bbd00f53e3d871f40d05a03d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-04 | 166 | 36 | 3 | e941df9a1091164edde3def8fc7d410186b2bd88 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-04 | 166 | 36 | 3 | aeda46bea5d8463c24a83b98b9ed92d962d733e5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-04 | 166 | 36 | 3 | 0f013bb5fdb72e88c2fc73d60cd01551a2db6341 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.28e-04 | 167 | 36 | 3 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.34e-04 | 168 | 36 | 3 | 6521bead9789d626b86cbd08692c621c5a5aef33 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 168 | 36 | 3 | f45dbcd7753117a3e41e1412bce2100d52fa7fd0 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.34e-04 | 168 | 36 | 3 | 95dc690c1987b05685d36e6bb20eb79308696e30 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 3.34e-04 | 168 | 36 | 3 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.34e-04 | 168 | 36 | 3 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 3.34e-04 | 168 | 36 | 3 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.39e-04 | 169 | 36 | 3 | c3ee781735a9288ce1822b230d39bb91c1415589 | |
| ToppCell | facs-SCAT-Fat-24m-Myeloid-myeloid_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-04 | 170 | 36 | 3 | 13480e5f2de50425e42be0144b876e9aa4006a68 | |
| ToppCell | facs-SCAT-Fat-24m-Myeloid-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-04 | 170 | 36 | 3 | d22cd09a43a14045bb1181189fe8accf78fdde3b | |
| ToppCell | facs-SCAT-Fat-24m-Myeloid|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-04 | 170 | 36 | 3 | f9968d3735328a39157764343dd40f1ad8bf710d | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-basal_late|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.45e-04 | 170 | 36 | 3 | 83320d37f0fc74e492cfe3de18f5c499eaa9fd3e | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.51e-04 | 171 | 36 | 3 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.57e-04 | 172 | 36 | 3 | bc3ed05fdd94d5e1f19285aea867b1453292baec | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-04 | 173 | 36 | 3 | 63f03abca84ae021ff34ff34537838aa8a1ccd11 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 3.63e-04 | 173 | 36 | 3 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.63e-04 | 173 | 36 | 3 | 23e50492bc673aff9df95d97f0b9be4ce57cbf01 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.70e-04 | 174 | 36 | 3 | c9d4e375dedd2b099a9ed70ec38ff35bbb0ce48a | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.70e-04 | 174 | 36 | 3 | 0d8e737860120dcd3a6b57992c612595904d585e | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.70e-04 | 174 | 36 | 3 | 1463c98f8f519dd030587abbdbeb1b4e1bca5dd1 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.70e-04 | 174 | 36 | 3 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.70e-04 | 174 | 36 | 3 | d421c0069d24cb560a3a429929e3cd1eceaeabcf | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma-schwann_cells|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.76e-04 | 175 | 36 | 3 | 8b010220cdfb680ec839572f4933adfb85045ea6 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.76e-04 | 175 | 36 | 3 | 2ce8bcf9926862e723219b4246388428d0c3fdee | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.76e-04 | 175 | 36 | 3 | 0b579aeadcc06be83627391c0b01bd8605fdbdf3 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.76e-04 | 175 | 36 | 3 | bbce8b1a160b414c0bf643c21c4e5e78fbccb7e1 | |
| ToppCell | wk_20-22-Epithelial-PNS-Late_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.82e-04 | 176 | 36 | 3 | 81924471d8a8c5bd8eedf294c007e25b6cd3e417 | |
| Drug | SCT-1 | 2.54e-07 | 9 | 34 | 3 | CID000211458 | |
| Drug | H 85 | 7.73e-06 | 26 | 34 | 3 | CID006439306 | |
| Drug | AC1O5WLA | 1.20e-05 | 30 | 34 | 3 | CID006442113 | |
| Drug | betaARKct | 3.23e-05 | 6 | 34 | 2 | CID000002295 | |
| Disease | coronary aneurysm | 6.72e-06 | 35 | 31 | 3 | EFO_1000881 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 9.58e-05 | 447 | 31 | 5 | EFO_0000694, MONDO_0100096 | |
| Disease | Autism Spectrum Disorders | 9.78e-05 | 85 | 31 | 3 | C1510586 | |
| Disease | longevity | 2.15e-04 | 284 | 31 | 4 | EFO_0004300 | |
| Disease | Depressive disorder | 2.30e-04 | 289 | 31 | 4 | C0011581 | |
| Disease | temperament and character inventory | 2.91e-04 | 24 | 31 | 2 | EFO_0004825 | |
| Disease | caudate volume change measurement, age at assessment | 3.69e-04 | 27 | 31 | 2 | EFO_0008007, EFO_0021491 | |
| Disease | Parkinson's disease (biomarker_via_orthology) | 4.56e-04 | 30 | 31 | 2 | DOID:14330 (biomarker_via_orthology) | |
| Disease | HVA measurement, MHPG measurement | 8.13e-04 | 40 | 31 | 2 | EFO_0005131, EFO_0005133 | |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 1.07e-03 | 46 | 31 | 2 | EFO_0005325, HP_0012735 | |
| Disease | neuropsychological test | 1.15e-03 | 197 | 31 | 3 | EFO_0003926 | |
| Disease | response to cisplatin, platinum measurement | 1.42e-03 | 53 | 31 | 2 | EFO_0010154, GO_0072718 | |
| Disease | Bipolar Disorder | 1.50e-03 | 477 | 31 | 4 | C0005586 | |
| Disease | triacylglycerol 52:2 measurement | 1.53e-03 | 55 | 31 | 2 | EFO_0010414 | |
| Disease | response to lithium ion | 1.59e-03 | 56 | 31 | 2 | GO_0010226 | |
| Disease | IGA glomerulonephritis | 1.70e-03 | 58 | 31 | 2 | EFO_0004194 | |
| Disease | chronotype measurement | 2.10e-03 | 882 | 31 | 5 | EFO_0008328 | |
| Disease | Schizophrenia | 2.11e-03 | 883 | 31 | 5 | C0036341 | |
| Disease | word reading | 2.13e-03 | 65 | 31 | 2 | EFO_0005300 | |
| Disease | schizophrenia (implicated_via_orthology) | 2.33e-03 | 68 | 31 | 2 | DOID:5419 (implicated_via_orthology) | |
| Disease | joint damage measurement | 2.33e-03 | 68 | 31 | 2 | EFO_0005413 | |
| Disease | Mental Depression | 2.37e-03 | 254 | 31 | 3 | C0011570 | |
| Disease | Autistic Disorder | 2.56e-03 | 261 | 31 | 3 | C0004352 | |
| Disease | temporal horn of lateral ventricle volume measurement | 2.61e-03 | 72 | 31 | 2 | EFO_0010333 | |
| Disease | methylcobalamin deficiency type cblE | 2.75e-03 | 74 | 31 | 2 | MONDO_0009354 | |
| Disease | response to angiotensin-converting enzyme inhibitor | 3.05e-03 | 78 | 31 | 2 | EFO_0005325 | |
| Disease | nicotine dependence symptom count | 3.28e-03 | 285 | 31 | 3 | EFO_0009262 | |
| Disease | age at menarche | 3.32e-03 | 594 | 31 | 4 | EFO_0004703 | |
| Disease | response to selective serotonin reuptake inhibitor | 3.37e-03 | 82 | 31 | 2 | EFO_0005658 | |
| Disease | congestive heart failure (is_marker_for) | 3.37e-03 | 82 | 31 | 2 | DOID:6000 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TAYDSSADWFSLGCM | 366 | P35626 | |
| SDFRWGSSISYSCMD | 3111 | Q96PZ7 | |
| SDFMWGSSVTYACLE | 3026 | Q7Z408 | |
| LSFAMDSYGTSNNCW | 691 | Q6QNK2 | |
| STEYSTCLDMWGVGC | 306 | O94921 | |
| VAYDSSADWFSLGCM | 366 | P25098 | |
| TMSGCAADCQYWERL | 116 | P28062 | |
| CAASGFTVSSNYMSW | 41 | A0A0C4DH42 | |
| TEAGTMALCYSAAWD | 591 | O60524 | |
| SYSNIEEDCTMCPSW | 741 | Q6ZU64 | |
| WSMCSGADSFTQECM | 251 | O15055 | |
| YNDSICDAGWTMFCQ | 461 | Q6UY01 | |
| QQWEGFTCDCSMTSY | 1066 | Q9Y4C0 | |
| CSYWKMSSACATARA | 386 | Q5XXA6 | |
| QWDGFSCDCSMTSFS | 1101 | Q9ULB1 | |
| MWNSSDANFSCYHES | 1 | Q9NQS5 | |
| CTNFSSCWSDGKMFN | 216 | Q9UPN3 | |
| GCAAQMFFSASWACT | 96 | Q8NGY1 | |
| DTWLDSAGMIYCRCN | 551 | Q9NXS3 | |
| CGENLYMSSASSSWS | 96 | P54108 | |
| LGITNCSELCMWYES | 171 | Q6GMR7 | |
| MSVCSSAYSDSWQVD | 6 | P60369 | |
| MSVCSSAYSDSWQVD | 6 | P60412 | |
| CAASGFTVSSNYMSW | 41 | P01767 | |
| SGGCYQMAVTTWLSC | 136 | A6ND48 | |
| VAGGWETQYMCCSAA | 1006 | Q8N1G1 | |
| DEYNCSSGMCIRSSW | 1161 | Q92673 | |
| CYSMDDSEDTSWDFG | 946 | Q14191 | |
| WQSNNTFASCSTDMC | 316 | Q9BZK7 | |
| MEWGCACSPSFSSYD | 901 | Q8N2E2 | |
| MAANCTSSWSLGESC | 1 | Q9BUG6 | |
| LCDFDGCGWNFTSMS | 451 | P98168 | |
| WVYSCAFSPDSSMLC | 216 | Q9Y6I7 | |
| SCDFYAWTSDNVACM | 1626 | P01266 | |
| MAANCTSSWSLGESC | 1 | A6NGD5 | |
| DCNCDGYASSMWTIS | 316 | P16519 |